This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated SLC5A8 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-SLC5A8 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~66.6 kDa | |
| Observed band | Approximately 67 kDa | |
| Gel | 10–12% | |
| Negative control | siRNA / KO lysate |
| PTM | Glycosylated | |
| Caveat | Glycosylation-based mobility shift | |
| Regulation | LPS-induced | |
| Isoform | 1 isoform(s) |
Literature-validated Western blot parameters for SLC5A8 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | mouse kidney . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-SLC5A8 antigen affinity purified polyclonal antibody (Catalog # A03883-3) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for SLC5A8 at approximately 67 kDa. The expected band size for SLC5A8 is at 67 kDa |
| Gel % | 10–12% |
| Load | 30 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 67 kDa |
SLC5A8 has a 66.6 kDa predicted backbone but runs at approximately 67 kDa, a small shift attributable to its single N-glycosylation site at Asn485.
| single band at approximately 67 kDa | matches the predicted 66.6 kDa monomeric mass of full-length SLC5A8, with only a modest upward shift |
| band running slightly above the 66.6 kDa predicted mass | reflects the added mass from the single N-linked glycan at Asn485 |
| no additional lower-molecular-weight cleavage product | SLC5A8 has no annotated signal peptide or propeptide, so the full-length precursor is itself the mature membrane-embedded form |
| no additional bands from alternate transcripts | only one isoform is annotated for SLC5A8, so a single band is expected rather than a multi-band ladder |
| band present or absent depending on tissue source | SLC5A8 is restricted to the apical membrane of specific epithelial cells (kidney, colon, thyroid), so signal is tissue-dependent rather than a technical failure |
| no shift to roughly double the monomer mass under non-reducing conditions | no disulfide bonds are annotated, so no covalent homodimer band is expected regardless of reduction |
| Predicted mass (66.6 kDa, 610 aa) | sets the baseline unmodified migration position for the full-length monomer |
| N-glycosylation at Asn485 | adds modest mass, shifting the native band slightly above 66.6 kDa toward the observed ~67 kDa |
| Absence of signal peptide or propeptide | no precursor-to-mature cleavage occurs, so no separate smaller processed band is expected |
| Absence of annotated disulfide bonds | no covalent homodimer forms, so reducing versus non-reducing conditions should not change the apparent band size |
| Single annotated isoform | no isoform-driven secondary bands are expected; extra bands point to degradation or nonspecific binding rather than splice variation |
| Multi-pass apical membrane protein | incomplete solubilization or aggregation of this membrane protein can cause smearing or higher-apparent-mass species on standard SDS-PAGE |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | SLC5A8 expression is restricted to the apical membrane of kidney, colon, and thyroid epithelia and is absent from non-expressing tissues or cell lines | confirm the sample is from a tissue known to express SLC5A8 and include a validated positive-control lysate |
| Band higher than expected | incomplete solubilization or aggregation of this multi-pass membrane protein, compounded by its N-linked glycan | use a membrane-optimized lysis buffer with adequate detergent and avoid boiling the sample at high temperature before loading |
| Broad smear instead of sharp band | heterogeneous glycosylation at the single N-linked site combined with membrane protein aggregation | treat a parallel sample with PNGase F to sharpen the band and optimize gel percentage and transfer conditions for membrane proteins |
| Multiple bands | only one isoform is annotated, so additional bands more likely reflect nonspecific antibody binding or degradation than splice variants | validate antibody specificity with a knockdown or knockout control and add fresh protease inhibitors during lysis |
| Weak or no signal | low native abundance outside apical-membrane-expressing tissues, or inefficient transfer of a large hydrophobic multi-pass membrane protein | load more total protein, extend transfer time for large membrane proteins, and confirm use of an expressing tissue |
| Fragments below expected size | proteolytic degradation during lysis, since no propeptide or signal-peptide cleavage is annotated for this protein | keep samples cold throughout preparation and use fresh protease-inhibitor-supplemented lysis buffer |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for SLC5A8, answered from its protein features.
BosterBio's SLC5A8 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
This anti-SLC5A8 antibody is our top-performing, extensively cited, thoroughly validated Western blot reagent, cross-confirmed through negative-tissue controls and complementary methods, giving researchers a dependable, high-confidence choice for specific, reproducible SLC5A8 detection.
Which to pick: Only one Boster anti-SLC5A8 antibody is listed here, A03883-3, which includes an actual Western blot validation image, making it the clear, evidence-backed pick for your SLC5A8 Western blot experiments.